| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/29/2007 | WO2006126010A3 Use of dna-pk inhibition to sensitise atm deficient cancers to dna-damaging cancer therapies |
| 03/29/2007 | WO2006124044A3 Protein scaffolds and viral particles for detecting analytes |
| 03/29/2007 | WO2006119292A3 Methods for detection of biological substances |
| 03/29/2007 | WO2006116351A3 Method for the early detection of renal disease using proteomics |
| 03/29/2007 | WO2006113710A3 Luminescent atp detection with extended linearity |
| 03/29/2007 | WO2006109278A3 Method for determination of analyte concentrations and related apparatus |
| 03/29/2007 | WO2006106336A3 Rat primers |
| 03/29/2007 | WO2006106331A3 Mouse primers |
| 03/29/2007 | WO2006105038A3 Methods of altering gene expression and methods of treatment utilizing same |
| 03/29/2007 | WO2006104498A3 Hydrogel-supported porous semiconductor devices |
| 03/29/2007 | WO2006090810A3 Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides |
| 03/29/2007 | WO2006089233A3 Methods and systems for diagnosis, prognosis and selection of treatment of leukemia |
| 03/29/2007 | WO2006088895A3 Compositions and methods for detecting pathogen specific nucleic acids in urine |
| 03/29/2007 | WO2006086499A3 Nucleozymes and methods of use |
| 03/29/2007 | WO2006085684A3 Method of diagnosing bladder cancer |
| 03/29/2007 | WO2006066224A3 Virulence targeted antibiotics |
| 03/29/2007 | WO2006060663A3 Reflex supplemental testing - a rapid, efficient and highly accurate method to identify subjects with an infection, disease or other condition |
| 03/29/2007 | WO2006012361A3 Genetic markers for predicting disease and treatment outcome |
| 03/29/2007 | WO2005113834A3 Single label comparative hybridization |
| 03/29/2007 | WO2005074524A3 Modified human interferon polypeptides and their uses |
| 03/29/2007 | WO2005019235A3 Use of novel compounds to release nucleotides from living cells |
| 03/29/2007 | WO2004081197A3 Immune response associated proteins |
| 03/29/2007 | US20070074298 Versican and epithelial-mesenchymal interaction |
| 03/29/2007 | US20070074297 TAAR1 knock out animal |
| 03/29/2007 | US20070074295 Schizophrenia related gene |
| 03/29/2007 | US20070073192 Multi-purpose vaginal moisture screening |
| 03/29/2007 | US20070073190 Digital type color comparisons in vaginal moisture pH determination |
| 03/29/2007 | US20070073047 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics |
| 03/29/2007 | US20070072823 siRNA targeting survivin |
| 03/29/2007 | US20070072818 Endothelial growth factors; antiischemic agents; neovascularization |
| 03/29/2007 | US20070072815 Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration |
| 03/29/2007 | US20070072807 Method of screening compounds |
| 03/29/2007 | US20070072805 Fusion peptide-induced hemolysis effectively inhibited by peptides of the invention compared to virus-inhibitory peptide (VIRIP); peptide blocks cellular infection by HIV particles by interacting with the fusion peptide of HIV viral glycoprotein 41 (gp41) to prevent virus entry into thecell |
| 03/29/2007 | US20070072794 Novel genes and proteins encoded thereby |
| 03/29/2007 | US20070072308 Methods of forming monolayers of phage-derived products and uses thereof |
| 03/29/2007 | US20070072287 Biomems cartridges |
| 03/29/2007 | US20070072270 PS4 variant with a proline substitution, derivable from a parent polypeptide, having non-maltogenic exoamylase activity; higher thermostability compared to the parent polypeptide |
| 03/29/2007 | US20070072266 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof |
| 03/29/2007 | US20070072261 Nucleic acids encoding PAK5 polypeptidesm and methods of use thereof |
| 03/29/2007 | US20070072260 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 03/29/2007 | US20070072257 Multiwell plate assembly for use in high throughput assays |
| 03/29/2007 | US20070072256 Optical molecular sensors for cytochrome p450 activity |
| 03/29/2007 | US20070072255 Toxicity detector for liquid consumable by humans |
| 03/29/2007 | US20070072254 Reacting 4-methyl-5-alkoxy-oxazole with substituted dihydro-(1,3)-dioxepin compound, in absence of solvent and catalyst to give product mixture consisting of Diels-Alder adducts; distillation; hydrolysis; deblocking, deprotecting; deacylation |
| 03/29/2007 | US20070072253 Method of Determining Standard Activity Value of Nattokinase |
| 03/29/2007 | US20070072240 Method for producing an in vitro expression library |
| 03/29/2007 | US20070072233 Methods and systems for facilitating the diagnosis and treatment of schizophrenia |
| 03/29/2007 | US20070072232 Identification of genetic components of drug response |
| 03/29/2007 | US20070072231 Tumor suppressor gene |
| 03/29/2007 | US20070072230 tubulin; inhibitor of cell proliferation; for drug screening |
| 03/29/2007 | US20070072229 Method for isolation, amplification and quantitation of ribonucleic acid |
| 03/29/2007 | US20070072228 ERCC2 polymorphisms |
| 03/29/2007 | US20070072227 Indicators can be used as an acute predictive marker for monitoring and screening for Notch-related toxicity due to gamma-secretase inhibition in both animal models and humans; used to identify preferred doses of test compounds and thereby prevent medical complications in clinical trials |
| 03/29/2007 | US20070072226 Mining protein interaction networks |
| 03/29/2007 | US20070072225 Antibodies with simultaneous subsite specificities to protein and lipid epitopes |
| 03/29/2007 | US20070072224 Diagnosis and treatment of tumor-suppressor associated disorders |
| 03/29/2007 | US20070072223 Compositions and methods for purifying nucleic acids |
| 03/29/2007 | US20070072222 FABP4 as biomarker for toxic effect |
| 03/29/2007 | US20070072221 Methods to screen peptide display libraries using minicell display |
| 03/29/2007 | US20070072220 Non-fouling polymeric surface modification and signal amplification method for biomolecular detection |
| 03/29/2007 | US20070072219 Detection method of homologous sequences differing by one base on a microarray |
| 03/29/2007 | US20070072218 A polynucleotide encoding a polypeptide having the amino acid sequence of SEQ ID NO:1, sequence operably linked to a heterologous promoter selected from hsp68, SV40, CMV, GAL4UAS, HSV and beta -actin; anticarcinogenic agents |
| 03/29/2007 | US20070072217 XAF genes and polypeptides: methods and reagents for modulating apoptosis |
| 03/29/2007 | US20070072216 distinguishing primary and secondary glioblastoma multiforme (GBM) in humans; determining the expression levels of Achaete-scute complex-like 1 gene (ASCL1), Hairy and Enhancer of Split 1 and 6 genes |
| 03/29/2007 | US20070072215 Nucleic acid-based logic circuits |
| 03/29/2007 | US20070072214 Two or three markers (preferably N-terminal and C-terminal epitopes) are introduced into the nascent protein and the resulting wild-type and mutant proteins are detected by mass spectrometry; facilitate detection and analysis of nascent proteins translated within cellular or cell-free translation system |
| 03/29/2007 | US20070072213 Quality control of gel-element microarrays, typically prepared by dispensing a gel-forming composition on a solid substrate such as glass or plastic surfaces |
| 03/29/2007 | US20070072212 Use of markers including nucleotide sequence based codes to monitor methods of detection and identification of genetic material |
| 03/29/2007 | US20070072211 Asymmetric PCR coupled with post-PCR characterization for the identification of nucleic acids |
| 03/29/2007 | US20070072210 Use of brca1-associated protein to treat and screen for dna damage and to identify therapeutics that promote a dna damage response |
| 03/29/2007 | US20070072209 Methods of treatment and diagnosis of Kaposi's sarcoma (KS) and KS related diseases |
| 03/29/2007 | US20070072208 sequencing; allow the generation of additional information about the location of short sequence reads in a genome |
| 03/29/2007 | US20070072207 Production of vaccines |
| 03/29/2007 | US20070072206 nucleotide sequences used for genetic replication of chaperone protein targets, to improve the representation of diverse sequences in chaperone protein product libraries derived from complex templates |
| 03/29/2007 | US20070072205 Nanomaterial error correction |
| 03/29/2007 | US20070072204 Compositions and methods for cancer diagnosis and treatment |
| 03/29/2007 | US20070072203 Insulin dependant diabetes; obesity; cachexia; anorexia; genomics; proteomics |
| 03/29/2007 | US20070072202 toll-like receptors; lipoproteins |
| 03/29/2007 | US20070072201 Method for producing improved nucleic acid oligomer functional homogeneity and functional characteristic information and results and oligomer application results |
| 03/29/2007 | US20070072200 useful in screening for small molecule inhibitors of X4 vs R5 viruses, for focusing antiviral therapies based on the predominant or exclusive type of HIV-1 virus present (X4 vs R5) and for creating templates for rational vaccine design |
| 03/29/2007 | US20070072199 Covalent methods for immobilization of thiolated biomolecules on siliceous and metallic surfaces |
| 03/29/2007 | US20070072198 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 03/29/2007 | US20070072197 Microtags for detection and identification of materials |
| 03/29/2007 | US20070072196 A nucleoside coupled to a chain of 4-6 phosphate and linked distantly to nonhydrolysing groups and the label for greater stability and processibility when incorporated by polymerase into growing polynucleotide strands in a template dependent synthesis; biosynthesis; DNA sequencing; hybridization assays |
| 03/29/2007 | US20070072195 Bio-commemorative article incorporating amplified genetic material |
| 03/29/2007 | US20070072194 Global transcription machinery engineering |
| 03/29/2007 | US20070072193 Ligand arrays having controlled feature size, and methods of making and using the same |
| 03/29/2007 | US20070072192 Novel polypeptides encoded by essential bacterial genes |
| 03/29/2007 | US20070072191 Infectious pestivirus pseudo-particles containing functional erns, e1, e2 envelope proteins |
| 03/29/2007 | US20070072190 System and method for universal identification of biological humans |
| 03/29/2007 | US20070072189 Artificial mutation controls for diagnostic testing |
| 03/29/2007 | US20070072188 Methods for detection of mycobacterium tuberculosis |
| 03/29/2007 | US20070072187 Novel methods and apparatus for cell based microarray assays |
| 03/29/2007 | US20070072186 Methods and agents for screening for compounds capable of modulating her2 expression |
| 03/29/2007 | US20070072185 Carbohydrate-binding modules of a new family |
| 03/29/2007 | US20070072184 genetic screens based on genotyping of the p21E2c31 polymorphism and/or the p21E3+20 C/T polymorphism in the p21cip 1 gene |
| 03/29/2007 | US20070072183 Topoisomerase hybrids and methods of use |
| 03/29/2007 | US20070072182 Methods for amplification of nucleic acid sequences using staggered ligation |
| 03/29/2007 | US20070072181 Combination therapy for treating alphavirus infection and liver fibrosis |
| 03/29/2007 | US20070072180 Using presence of polymorphism in allelic profile of nucleotide-binding oligomerization domain containing 2 (NOD2) gene as diagnostic indicatory of inflammatory disorders |